Nalaganje...

Immunotherapy in pancreatic adenocarcinoma—overcoming barriers to response

Pancreatic adenocarcinoma (PAC) remains one of the leading causes of cancer-related death. Despite multiple advances in targeted and immune therapies, the 5-year survival in advanced PAC remains poor. In this review, we discuss some of the unique aspects of the tumor microenvironment (TME) in PAC th...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Gastrointest Oncol
Main Authors: Rosenberg, Ari, Mahalingam, Devalingam
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2018
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5848027/
https://ncbi.nlm.nih.gov/pubmed/29564181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.01.13
Oznake: Označite
Brez oznak, prvi označite!